Strengthen targeting of beauty and skin care markets...Dongkuk Pharmaceutical Signs Domestic Distribution Agreement With Medifab, Skin Booster Madechiel
Oct 14, 2025
|
'Madequiel' is a high-functioning skin booster that combines Dongkuk Pharmaceutical's representative ingredient, TECA (Centella Asiatica Quantitative Extract), and Medipab's high-purity chitosan-based LTG (Liquid-To-Gel) technology, and is considered a next-generation solution as a differentiated mechanism of action from existing skin boosters.
Dongkuk Pharmaceutical plans to further strengthen its targeting in the beauty and skin care markets by signing a domestic distribution contract for the skin booster 'Madequiel'. Based on the research and development know-how of HA filler 'Belast', which has been used steadily for 13 years, Dongkuk Pharmaceutical has recently launched a new product 'Cablelin' and is expanding its lineup of medical aesthetic products such as botulinum toxin 'Vienox' and adhesive transparent window cover 'MadekaMD cream and lotion'.
An official from Dongguk Pharmaceutical Medical Aesthetic said "'Madequiel' is a product containing the essence of technology based on scientific evidence rather than simply following the trend."We will continue to expand our differentiated aesthetic portfolio based on functionality and safety in the future."
This article was translated by Naver AI translator.